Sinocelltech Group Ltd. (688520.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 33.01

From 52W high−11.11%

Volume2.34M

Market capCNY 17.12B

P/E (TTM)−30.3x

P/S (TTM)11.6x

Div yield—

Key dataSep 18, 2026

Open

CNY 33.01

From 52W high

−11.11%

Volume

2.34M

Market cap

CNY 17.12B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−63.7x

P/E (TTM)

−30.3x

RSI (14)

44.5

MomentumView details →

1D Return

−3.96%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−30.3x

EV/EBITDA

−63.7x

EV/Sales

12.5x

P/S (TTM)

11.6x

P/B (TTM)

241.7x

ProfitabilityView details →

Gross Margin

91.58%

Net Margin

−58.98%

EBITDA Margin

−19.57%

ROE (TTM)

−94.89%

ROA (TTM)

−17.74%

Asset Turnover

0.33x

GrowthView details →

Revenue YoY

−43.65%

EPS YoY

—

FCF YoY

−12.67%

Revenue CAGR 3Y

+15.10%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−3.96%

YTD Return

—

1Y Return

—

RSI (14)

44.5

vs 50D SMA

−5.83%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

3.06x

Current Ratio

0.98x

Quick Ratio

0.85x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−CNY 0.40

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

1.36B

Net Income (TTM)

−804.31M

Op. CF (TTM)

−261.57M

Next earningsOct 23, 2026 →

Latest newsMore news →

Four shareholders of Sinocelltech plan to reduce their combined stake by no more than 0.94%.7d ago

Four shareholder and employee stock ownership platforms of Sino Biological announced plans to collectively reduce their stake in the company by no more than 0.94% of total shares between October 13, 2026 and January 12, 2027.7d ago

Similar companies

Shanghai Junshi Biosciences Co., Ltd.01877.HK 康希诺688185.SH Jazz Pharmaceuticals plcJAZZ Ascendis Pharma A/SASND 大参林603233.SH Exelixis, Inc.EXEL Find similar companies →

Latest newsMore news →

Four shareholders of Sinocelltech plan to reduce their combined stake by no more than 0.94%.7d ago Four shareholder and employee stock ownership platforms of Sino Biological announced plans to collectively reduce their stake in the company by no more than 0.94% of total shares between October 13, 2026 and January 12, 2027.7d ago SinoCell Technologies reported a net loss of 366 million yuan for the first half of 2026, compared with a loss of 33.77 million yuan in the same period of 2025.23d ago